![](/img/cover-not-exists.png)
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial
Neri, B., Cipriani, G., Fulignati, C., Turrini, M., Ponchietti, R., Bartoletti, R., Della Melina, A., Di Cello, V., Dominici, A., Maleci, D., Raugei, A., Villari, D., Nicita, G.Volume:
16
Language:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-200501000-00009
Date:
January, 2005
File:
PDF, 66 KB
english, 2005